Juvenescence LTD is Director of AgeX Therapeutics, Inc.. Currently has a direct ownership of 0 shares of AGE, which is worth approximately $0. The most recent transaction as insider was on Mar 14, 2023, when has been sold 16,447,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Juvenescence Ltd Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 14 2023
SELL
Bona fide gift
-
16,447,500 Reduced 100.0%
0 Common Stock
JL

Juvenescence LTD

Director
Ramsey, Y8

Track Institutional and Insider Activities on AGE

Follow AgeX Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGE shares.

Notify only if

Insider Trading

Get notified when an Age X Therapeutics, Inc. insider buys or sells AGE shares.

Notify only if

News

Receive news related to AgeX Therapeutics, Inc.

Track Activities on AGE